Plasma proteome in multiple sclerosis disease progression.
Arjan MalekzadehCyra LeursWessel van WieringenMartijn D SteenwijkMenno Michiel SchoonheimMichael AmannYvonne NaegelinJens KuhleJoep KillesteinCharlotte E TeunissenPublished in: Annals of clinical and translational neurology (2019)
Our results revealed eight novel biomarkers related to clinical and radiological progression in MS. These results indicate that changes in immune system, complement pathway and ECM remodeling proteins contribute to MS progression and may therefore be further explored for use in prognosis of MS.